Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

Top Pharma Companies in India by Market Cap

BSE Sensex 75397.74 938.21 (1.26%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
1	Biocon Ltd.	Q V PT	57,365 Mid Cap	354.35 (0.67%)	587.16	2.1	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Orchid Pharma Ltd.	Q V PT	4,989 Small Cap	825.60 (-0.89%)	575.67	3.18	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Healthcare Global Enterprises Ltd.	Q V+ PT	8,731 Small Cap	586.85 (0.35%)	522.51	5.42	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Aster DM Quality Care Ltd.	Q V+ PT	59,570 Mid Cap	687.70 (0.63%)	186.93	14.08	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Cohance Lifesciences Ltd.	Q V+ PT	17,005 Small Cap	447.60 (0.71%)	160.07	4.42	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Krishna Institute of Medical Sciences Ltd	Q V PT	29,480 Small Cap	712.10 (1.45%)	144.3	7.79	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Dishman Carbogen Amcis Ltd.	Q V+ PT	2,276 Small Cap	148.85 (2.55%)	140.82	0.34	8.93	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Tarsons Products Ltd.	Q V+ PT	1,552 Small Cap	295.60 (1.32%)	139.91	2.45	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Sai Parenterals Ltd.	Q V PT	2,302 Small Cap	513.95 (-1.35%)	139.47	2.95	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Dr. Agarwals Health Care Ltd.	Q V PT	16,117 Small Cap	512.45 (0.81%)	108.63	7.79	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Manipal Health Enterprises Ltd.	Q V+ PT	87,926 Mid Cap	640.05 (-4.25%)	98.54	5.3	41.64	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,374.75 (-0.72%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Rubicon Research Ltd.	Q V+ PT	26,650 Small Cap	1,682 (4.48%)	92.47	19.85	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Sai Life Sciences Ltd.	Q V+ PT	33,139 Small Cap	1,564.60 (0.31%)	91.61	12.98	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Divis Laboratories Ltd.	Q V+ PT	2,57,903 Large Cap	9,954.75 (2.47%)	88.17	14.6	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,595 (-0.87%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Solara Active Pharma Sciences Ltd.	Q V PT	3,055 Small Cap	627.60 (-0.86%)	82.7	2.13	-3.27	-145.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,289 Small Cap	165.90 (1.47%)	81.41	5	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	826.60 (-0.22%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Nephrocare Health Services Ltd.	Q V PT	6,194 Small Cap	611.90 (-0.66%)	80.61	5.46	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,460.05 (0.88%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Syngene International Ltd.	Q V+ PT	16,252 Small Cap	416.40 (3.43%)	76.91	3.44	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,390 (-0.12%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,902 (0.31%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Acutaas Chemicals Ltd.	Q V+ PT	32,770 Small Cap	3,980.15 (-0.56%)	74.62	17.64	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,194 (2.23%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Shilpa Medicare Ltd.	Q V+ PT	18,671 Small Cap	940.25 (-1.51%)	62.8	6.95	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Global Health Ltd.	Q V PT	34,122 Small Cap	1,310 (3.23%)	61.35	8.3	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Max Healthcare Institute Ltd.	Q V PT	83,706 Mid Cap	897.10 (4.31%)	60.63	7.39	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Indoco Remedies Ltd.	Q V+ PT	1,923 Small Cap	214.75 (3.07%)	60.22	1.88	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Indegene	628.45	6.94%
Advanced Enzyme Tech	280.15	6.54%
One Global Service	461	5.46%
Evonile Pharma	1,778.15	4.98%
Rubicon Research	1,682	4.48%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,187.70	-4.63%
Manipal Health Enter	640.05	-4.25%
Strides Pharma Scien	1,031.65	-3.51%
Sigachi Industries	25.50	-3.41%

News about Top Pharma Companies in India

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Manipal Health Enterprises informs about disclosure

Manipal Health Enterprises has informed that it enclosed Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 30, 2026 for MEMG International India.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Max Healthcare Inst. - Quaterly Results

The company witnessed a 14.30% growth in the revenue at Rs. 8419.70 millions for the quarter ended September 2026 as compared to Rs. 7366.20 millions during the year-ago period.Profit for the quarter ended September 2026 grew by 4.93% to Rs. 1683.30 millions from Rs. 1604.20 millions.Operating profit surged to 2786.40 millions from the corresponding previous quarter of 2611.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	8419.70	7366.20	14.30	16248.90	14306.40	13.58	28744.50	26636.00	7.92
Other Income	491.10	474.30	3.54	1412.10	1272.80	10.94	3019.50	3665.40	-17.62
PBIDT	2786.40	2611.00	6.72	5532.20	5286.60	4.65	11225.30	11999.30	-6.45
Interest	137.20	86.70	58.25	257.90	179.20	43.92	398.70	483.90	-17.61
PBDT	2649.20	2524.30	4.95	5274.30	5107.40	3.27	10670.20	10779.10	-1.01
Depreciation	387.70	367.70	5.44	753.70	722.00	4.39	1429.00	1311.90	8.93
PBT	2261.50	2156.60	4.86	4520.60	4385.40	3.08	9241.20	9467.20	-2.39
TAX	578.20	552.40	4.67	1161.30	1120.90	3.60	2075.10	2456.50	-15.53
Deferred Tax	-28.30	50.80	-155.71	-17.10	77.10	-122.18	196.70	482.90	-59.27
PAT	1683.30	1604.20	4.93	3359.30	3264.50	2.90	7166.10	7010.70	2.22
Equity	9733.10	9722.40	0.11	9733.10	9722.40	0.11	9731.30	9721.40	0.10
PBIDTM(%)	33.09	35.45	-6.64	34.05	36.95	-7.86	39.05	45.05	-13.31

Oct, 2026

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

The total consolidated income of the company has increased by 20.37% at Rs 2,610.11 crore for Q2FY27

Oct, 2026

Max Healthcare Institute informs about allotment under ESOP

Max Healthcare Institute has informed that Nomination & Remuneration Committee (“NRC”) of the Company in its meeting held today i.e. October 30, 2026, has approved the allotment of 16,803 equity shares having face value of ?10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Biocon Ltd.	57,365 Crore
2	Orchid Pharma Ltd.	4,989 Crore
3	Healthcare Global Enterprises Ltd.	8,731 Crore
4	Aster DM Quality Care Ltd.	59,570 Crore
5	Cohance Lifesciences Ltd.	17,005 Crore
6	Krishna Institute of Medical Sciences Ltd	29,480 Crore
7	Dishman Carbogen Amcis Ltd.	2,276 Crore
8	Tarsons Products Ltd.	1,552 Crore
9	Sai Parenterals Ltd.	2,302 Crore
10	Dr. Agarwals Health Care Ltd.	16,117 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,802	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,595	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,382	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,014	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,430	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,375	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,090	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,665	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,952	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,505	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,430	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,250	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,090	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,014	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,382	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,802	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,356	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about newspaper publication

Manipal Health Enterprises informs about disclosure

Max Healthcare Inst. - Quaterly Results

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

Max Healthcare Institute informs about allotment under ESOP

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?